Side-by-side comparison of AI visibility scores, market position, and capabilities
AI care enablement platform resolving 85% of patient inquiries within one day; $12M Series A from Molten Ventures helping clinics manage NHS and value-based care patient caseloads.
Anima is a care enablement platform that uses AI to help clinical teams manage patient caseloads more efficiently — enabling practices, clinics, and healthcare systems to handle more patient inquiries with the same clinical staff by triaging, routing, and pre-processing patient messages, symptoms, and administrative requests before they reach clinicians. Founded as a Y Combinator W21 graduate, Anima raised $14.5 million total including a $12 million Series A in early 2024 led by Molten Ventures with Hummingbird, achieving a benchmark of resolving 85% of patient inquiries within one day.\n\nAnima's platform integrates with existing EHR systems and clinical workflows — when patients submit messages or requests, Anima's AI layer categorizes the urgency, extracts relevant clinical context from the patient record, and routes to the appropriate care team member with pre-populated response templates and suggested actions. Administrative inquiries (prescription refills, appointment requests, test result questions) are handled with AI-assisted responses that clinicians can review and approve rapidly rather than composing from scratch. This reduces the cognitive load of clinical inbox management that contributes to physician burnout.\n\nIn 2025, Anima competes in the clinical workflow automation and care management platform market with Klara (patient communication), Luma Health (care orchestration), Healthie, and AI-powered EHR tools from Epic and athenahealth for clinical team productivity and patient communication. The UK National Health Service (NHS) has been a key market for Anima, given the NHS's acute GP workload crisis and the need for digital tools that help manage the high volume of patient contacts with limited clinical capacity. The 2025 strategy focuses on expanding within NHS primary care networks, growing in US value-based care organizations where managing population health efficiently is financially incentivized, and deepening AI capabilities for clinical decision support.
Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.
International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.